Jerry H. Gurwitz, MD

Articles by Jerry H. Gurwitz, MD

Quality Measurement of Medication Monitoring in the Meaningful Use Era

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Shira H. Fischer, AB,Shawn J. Gagne, BA,Daniel J. Peterson, MA, MS,Lawrence D. Garber, MD,Jerry H. Gurwitz, MD

September 7th 2011

Shifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Lawrence D. Garber, MD,Jennifer L. Donovan, PharmD,Abir O. Kanaan, PharmD,Marsha A. Raebel, PharmD,Yanfang Zhao, MA,Jacquelyne C. Fuller, MPH,Shawn J. Gagne, BA,Shira H. Fischer, AB,Jerry H. Gurwitz, MD

July 17th 2010

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.

Polypharmacy With Oral Antidiabetic Agents: An Indicator of Poor Glycemic Control

ByCynthia J. Willey, PhD,Susan E. Andrade, ScD,Joseph Cohen, MD,Jackie C. Fuller, MPH,Jerry H. Gurwitz, MD

August 1st 2006

Health Plan Members' Views on Forgiving Medical Errors

ByKathleen M. Mazor, EdD,Steven R. Simon, MD,Robert A. Yood, MD,Brian C. Martinson, PhD,Margaret J. Gunter, PhD,George W. Reed, PhD,Jerry H. Gurwitz, MD

January 15th 2005

Hypertension Management: The Care Gap Between Clinical Guidelines and Clinical Practice

BySusan E. Andrade, ScD,Jerry H. Gurwitz, MD,Terry S. Field, DSc,Michael Kelleher, MD,Sumit R. Majumdar, MD, MPH,George Reed, PhD,Robert Black, MD

July 1st 2004

Latest Updated Articles

Hypertension Management: The Care Gap Between Clinical Guidelines and Clinical Practice
Published: July 1st 2004 | Updated:
Health Plan Members' Views on Forgiving Medical Errors
Published: January 15th 2005 | Updated:
Polypharmacy With Oral Antidiabetic Agents: An Indicator of Poor Glycemic Control
Published: August 1st 2006 | Updated:
Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting
Published: July 17th 2010 | Updated:
Quality Measurement of Medication Monitoring in the Meaningful Use Era
Published: September 7th 2011 | Updated:

Jerry H. Gurwitz, MD

Articles by Jerry H. Gurwitz, MD

Quality Measurement of Medication Monitoring in the Meaningful Use Era

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Polypharmacy With Oral Antidiabetic Agents: An Indicator of Poor Glycemic Control

Health Plan Members' Views on Forgiving Medical Errors

Hypertension Management: The Care Gap Between Clinical Guidelines and Clinical Practice

Latest Updated Articles

Trending on AJMC

Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review

FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer

Supporting Pharmacy Residents in Completing Research Projects at UC Davis: Jeremiah J. Duby, PharmD, BCPS, BCCCP

Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program

Myasthenia Gravis–Induced Fears of Diagnosed Patients During the Pandemic